Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FL473
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $18,488
Award facts
- Contract value 100% obligated
- $18,488.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on October 28, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as contract 4569871206, represents performance through October 31, 2025, and requires fulfillment at the company's Park Ridge, IL location. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceuticals to Department of Defense military healthcare facilities worldwide.
As an approved PPV-G GEN V prime vendor contractor, DMS Pharmaceutical Group supplies a comprehensive portfolio of pharmaceutical products and medical consumables to support federal military medical operations, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The company's established performance across numerous delivery orders issued by the Defense Logistics Agency between October 2 and October 15, 2025 demonstrates its operational capability to fulfill the diverse pharmaceutical requirements of the military health system. The parent IDC under PPV-G GEN V carries a ceiling value of approximately $500 million with a completion date of December 31, 2036, positioning DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain serving Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DX26FL473?
SPE2DX26FL473 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 28, 2025.
How much is contract SPE2DX26FL473 worth?
The government has obligated $18,488 on SPE2DX26FL473.
Is contract SPE2DX26FL473 an order under another contract?
Yes. SPE2DX26FL473 is a delivery order under SPE2DX16D9414, an indefinite delivery contract.
Was contract SPE2DX26FL473 competed?
The extent of competition for SPE2DX26FL473 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award